Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Over 18 years old.~* Diagnosis of Chagas disease through two different serological tests.~* Positive T. cruzi PCR in peripheral blood.~* Signed informed consent.~Exclusion Criteria:~* Previous treatment with Benznidazole or Nifurtimox.~* Alcohol consumption.~* Acute or chronic health problems that could interfere in the assessment of the efficacy or safety of the drug (acute infections, HIV infection, liver or renal impairment, etc).~* Nitroimidazole hipersensitivity.~* Concomitant or previous treatment with allopurinol or antifungal drugs.~* Pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- B300/60 (Type: ACTIVE_COMPARATOR): Benznidazole 300mg/day p.o. divided in two doses for 60 days
- B150/60 (Type: EXPERIMENTAL): Benznidazole 150mg/day p.o. divided in two doses for 60 days
- B400/15 (Type: EXPERIMENTAL): Benznidazole 400mg/day p.o. divided in two doses for 15 days

Based on this trial design, predict the completion outcome and termination type (if applicable).